412 related articles for article (PubMed ID: 20670176)
1. Using genomics to develop novel antibacterial therapeutics.
Nagaraj NS; Singh OV
Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
[TBL] [Abstract][Full Text] [Related]
2. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
3. Use of genomics to select antibacterial targets.
Pucci MJ
Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
[TBL] [Abstract][Full Text] [Related]
6. Delivering novel targets and antibiotics from genomics.
Payne DJ; Holmes DJ; Rosenberg M
Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
[TBL] [Abstract][Full Text] [Related]
7. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
8. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
Dougherty TJ; Miller PF
IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
[TBL] [Abstract][Full Text] [Related]
9. Functional genomics in antibacterial drug discovery.
Freiberg C; Brötz-Oesterhelt H
Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
[TBL] [Abstract][Full Text] [Related]
10. Crystallizing new approaches for antimicrobial drug discovery.
Schmid MB
Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
[TBL] [Abstract][Full Text] [Related]
11. Bacterial genomics and pathogen evolution.
Raskin DM; Seshadri R; Pukatzki SU; Mekalanos JJ
Cell; 2006 Feb; 124(4):703-14. PubMed ID: 16497582
[TBL] [Abstract][Full Text] [Related]
12. Biocomputational strategies for microbial drug target identification.
Sakharkar KR; Sakharkar MK; Chow VT
Methods Mol Med; 2008; 142():1-9. PubMed ID: 18437301
[TBL] [Abstract][Full Text] [Related]
13. Genetic strategies for antibacterial drug discovery.
Miesel L; Greene J; Black TA
Nat Rev Genet; 2003 Jun; 4(6):442-56. PubMed ID: 12776214
[TBL] [Abstract][Full Text] [Related]
14. The role of genomics in the discovery of novel targets for antibiotic therapy.
Ji Y
Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140
[TBL] [Abstract][Full Text] [Related]
15. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
16. Genomic approaches to antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
[TBL] [Abstract][Full Text] [Related]
17. Structure-based approaches to antibiotic drug discovery.
Nicola G; Abagyan R
Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
[TBL] [Abstract][Full Text] [Related]
18. Using the genome to understand pathogenicity.
Field D; Hughes J; Moxon ER
Methods Mol Biol; 2004; 266():261-87. PubMed ID: 15148423
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial drug discovery--then, now and the genomics future.
Monaghan RL; Barrett JF
Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
[TBL] [Abstract][Full Text] [Related]
20. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
Singh NK; Selvam SM; Chakravarthy P
In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
